Second patient death reported with gene therapy for muscular dystrophy

  • Posted on June 16, 2025
  • By The Toronto Star
  • 2 Views
Second patient death reported with gene therapy for muscular dystrophy

WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
continue reading...

Author
The Toronto Star

You May Also Like